Perspective · 2 Feb 2026
Conference abstractPublished 12 Nov 2012
Delivering cytokine gene therapy to prostate tumors using adipose-derived mesenchymal stem cells
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
I t is critical to develop new therapeutic approaches for prostate cancer, since there is no effective treatment for patients in the advanced stages of this disease. And although many gene therapy approaches have been evaluated to date, clinical responses unfortunately remain poor. We have examined the potential of developing more effective cell-based gene therapies for preventing prostate cancer progression, using adipose-derived mesenchymal stem cells (ASC) as vehicles. ASC have gained interest as promising tools for delivering cancer therapy. Adipose tissue can be obtained readily in amounts sufficient for ASC isolation, which can be expanded rapidly, allowing its use at low passage numbers, and can be transduced by viral and nonviral means. And since current techniques allow isolation of ASC from an individual?s own adipose tissue, this could help prevent immune reaction, suggesting that ASC could be far more efficient as a gene delivery vehicle than viral vectors currently in clinical trials. The present study reports our observations using this novel gene therapy modality. In this study we have examined the potential of new antiangiogenesis and proapoptotic therapies delivered by ASC and evaluated their ability to reduce prostate tumor growth rate in vitro and in vivo. We expressed in ASC several antitumor cytokine therapies, and all were found to be highly effective in preventing tumor progression in vivo using prostate and breast cancer xenograft models. Overall, ASC-delivered PEDF prevented HUVEC tube formation in vitro and induced strong apoptosis of cocultured cancer cells, suggesting a potential bystander effect that might be useful for therapeutic applications. Similar antitumor findings were observed when Mda7 or IFNb were delivered by ASC, with induction of strong cell cycle arrest, and viability reduction by an increase in the apoptosis of cocultured tumor cells as assessed by Caspase 3/7 detection. The transgene expression was overall non-toxic and did not appear to interfere with the normal differentiation potential of ASC (osteogenesis or adipogenesis). We also observed that ASC retained their innate ability to migrate towards tumor cells in co-culture and this ability could be blocked by inhibition of CXCR4 signaling. ASC were found to be non-tumorigenic in vitro using a soft agar assay, as well as in vivo , utilizing two prostate cancer xenograft models. PEDF was the most promising therapeutic cytokine delivered, and completely prevented prostate tumor establishment in vivo of both the TC2Ras and PC3 highly aggressive prostate cancer models. In conclusion, ASC expressing antitumor cytokines could effectively reduce prostate tumor growth in vivo , suggesting ASC-cytokine therapies might have translational applications. Future studies will aim to target cytokines to tumor tissues by virtue of peptide targeting moieties to enhance cytokine therapy effects
Subjects
BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Cell Science & Therapy.
Commentary · 2 Feb 2026
Metabolism Regulation and Its Influence on Therapeutic Development in Human Disease
Commentary · 2 Dec 2025
Cellular Membranes and Transport Proteins as Regulators of Homeostasis and Metabolic Coordination
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cell Science & Therapy
- SubjectBiology
- BylineArticles whose byline prints “Marxa L. Figueiredo”

